Filter
244
Text search:
drug
formulations
Featured
Recommendations
34
New Publications
66
Language
Document type
No document type
134
Guidelines
53
Studies & Reports
35
Manuals
11
Fact sheets
4
Strategic & Response Plan
3
Training Material
2
App
1
Resource Platforms
1
Countries / Regions
Kenya
15
India
14
Ghana
6
Malawi
6
Western and Central Europe
6
Tanzania
5
Rwanda
5
South Africa
5
Bangladesh
5
Global
5
Africa
4
Sierra Leone
3
Nigeria
3
Ethiopia
3
Nepal
3
Latin America and the Carribbean
3
Eastern Europe
3
Cameroon
2
Uganda
2
Zimbabwe
2
Zambia
2
Syria
2
Botswana
2
Middle East and North Africa
2
South–East Asia Region
2
Russia
2
Burkina Faso
1
Liberia
1
Senegal
1
Congo, Democratic Republic of
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Niger
1
Haiti
1
Philippines
1
Pakistan
1
South Sudan
1
Afghanistan
1
Cambodia
1
Benin
1
Eswatini/ Swaziland
1
Madagascar
1
Myanmar / Burma
1
Sri Lanka
1
Yemen
1
East and Southern Africa
1
Bhutan
1
Congo-Brazzaville
1
Tajikistan
1
France
1
Authors & Publishers
Publication Years
Category
Countries
77
Clinical Guidelines
55
Public Health
10
Women & Child Health
10
Pharmacy & Technologies
6
Key Resources
4
Capacity Building
2
Toolboxes
HIV
41
TB
34
Pharmacy
21
AMR
14
Mental Health
12
NTDs
9
COVID-19
8
NCDs
8
Rapid Response
5
Caregiver
4
Ebola & Marburg
3
Polio
3
Planetary Health
3
2.0 Rapid Response
3
Disability
2
Refugee
2
Malaria
2
Conflict
1
Specific Hazards
1
Global Health Education
1
Update 2021; Immunization, Vaccines and Biologicals
Временное руководство23 декабря 2020 г.
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expan
...
Confronted with the important issue of patient safety, in 2002 the Fifty-fifth World Health Assembly adopted a resolution urging countries to pay the closest possible attention to the problem and to strengthen safety and monitoring systems. In May 2004, the Fifty-seventh World Health Assembly approv
...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen
...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities
...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from
...
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of medicines for acute and chronic conditions as well as opinions and perceptio
...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll
...
